Dr. Ganz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Center
10833 LeConte Ave., A2-125 CHS
Los Angeles, CA 90095Phone+1 310-206-1404Fax+1 310-206-1404
Summary
- I am a medical oncologist and Distinguished Professor of Health Policy & Management AND Medicine at the UCLA Schools of Public Health and Medicine. I am also the Associate Director for Population Science at the UCLA Jonsson Comprehensive Cancer Center. I was elected to the Institute of Medicine (IOM) in 2007, now National Academy of Medicine (NAM). I also served on the National Cancer Institute Board of Scientific Advisors from 2002-2007 and on the American Society of Clinical Oncology (ASCO) Board of Directors from 2003-2006. I received the American Cancer Society Medal of Honor in 2010. In my research I have pioneered the assessment of quality of life in cancer patients, and have focused much of my clinical and research efforts in the areas of breast cancer and its prevention. My major areas of research include cancer survivorship and the late effects of cancer treatment, measurement of patient reported outcomes in clinical treatment trials, and quality of care for cancer patients.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1976 - 1978
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1973 - 1976
- David Geffen School of Medicine at UCLAClass of 1973
Certifications & Licensure
- CA State Medical License 1974 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:LA Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease Start of enrollment: 1994 Apr 01
- SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial Start of enrollment: 1997 Feb 01
- Letrozole in Preventing Breast Cancer in Postmenopausal Women Start of enrollment: 2002 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis: One Decade Later.Larissa Nekhlyudov, Laura A Levit, Patricia A Ganz
Journal of Clinical Oncology. 2024-12-20 - Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04.John Devin Peipert, Jessica Roydhouse, Mourad Tighiouart, Norah Lynn Henry, Sungjin Kim
Quality of Life Research. 2024-11-01 - Transcriptomic markers of biological aging in breast cancer survivors: a longitudinal study.Judith E Carroll, Catherine M Crespi, Steve Cole, Patricia A Ganz, Laura Petersen
Journal of the National Cancer Institute. 2024-10-08
Journal Articles
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization StudySusan M Domchek, Wendy K Chung, Patricia A Ganz, Robert L Nussbaum, Journal of the National Cancer Institute
- Reproductive and Gynecological Complication Risks Among Thyroid Cancer SurvivorsMarcus Monroe, Patricia A Ganz, Journal of Cancer Survivorship
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer RiskPatricia A Ganz, Amanda E Toland, Susan M Domchek, Tanja Pejovic, Clinical Cancer Research
- Join now to see all
Press Mentions
- Quality-of-Life Outcomes Reported from NRG Oncology Trial Studying Whole-Breast Irradiation vs Accelerated Partial-Breast Irradiation After Breast-Conserving SurgerySeptember 16th, 2024
- Breast Cancer Survivors Need a Comprehensive Care Plan, Says DoctorMay 19th, 2023
- Expert Panel That Sparked Mammogram Controversy Now Says Tests Should Start at 40May 9th, 2023
- Join now to see all
Grant Support
- Patients And SurvivorsNational Cancer Institute2009–2012
- Enhancing Outcomes In Young Breast Cancer Survivors: A Program Of The Ucla-LivestNational Center For Chronic Disease Prev And Health Promo2011
- Vitamin D In Breast Cancer: A Cross-Sectional Observational Study In Recently DINational Center For Research Resources2010
- The UCLA Familial Cancer Registry And Genetic Evaluation ProgramNational Center For Research Resources2009–2010
- Cognitive Functioning After Breast Cancer TreatmentNational Cancer Institute2006–2010
- Does Blocking Proinflammatory Cytokines Diminish Cancer-Related Fatigue?National Center For Research Resources2006–2008
- The Biopsychosocial Mechanisms Of Fatigue In Breast Cancer SurvivorsNational Center For Research Resources2005
- Endocrine /Immune Responses To Stress In Breast Cancer SNational Center For Research Resources2004
- Biopsychosocial Mechanisms Of Fatigue In Breast CancNational Center For Research Resources2004
- Missed Opportunities For Early Detection &Treatment For Colorectal CancerAgency For Healthcare Research And Quality2000–2002
- Breast Cancer--Preparing For SurvivorshipNational Cancer Institute1998–2002
- Intraductal Breast Pathology In High Risk WomenNational Center For Research Resources2001
- Improving Colorectal Cancer Screening RatesNational Cancer Institute1998–2001
- Psychological WELL Being In Long Term Cancer SurvivorsNational Cancer Institute1999
- Breast Cancer SurvivorsNational Cancer Institute1994–1998
- Breast Cancer Prevention And Control In Older WomenNational Institute On Aging1994–1997
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: